WhiteBoard style discussion on preliminary reports from Synairgen regarding their randomized, double blinded, placebo controlled trial on SNG001, which is an inhaled interferon beta, for the treatment of COVID-19. They have not yet published the data, so our only information…
‘The reality is, in terms of background immunity, there just isn’t much,’ says Dr. David Naylor, co-chair of the COVID-19 Immunity Task Force. The preliminary results of 10,000 blood samples analyzed shows less than 1% had antibodies to the novel…
US biotech firm Inovio on Tuesday reported encouraging results in preliminary clinical trials for its Covid-19 vaccine candidate. #Vaccine #Coronavirus #COVID19 #Inovio #DonaldTrump #WarpSpeed #INO4800 Follow us on: Website: Facebook: Twitter: Instagram: